OL
AVNS

Odyssean LLC’s Avanos Medical AVNS Stock Holding History

Odyssean LLC’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Buy
+12,116
New +$163K 0.06% 385

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Odyssean LLC's AVNS Position: Q1 2026 in Review

Odyssean LLC opened a new position in Avanos Medical (AVNS) in Q1 2026: 12,116 shares worth $170K. The stake represents 0.06% of the portfolio and ranks #385 among its holdings.

257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Odyssean LLC held 12,116 shares of Avanos Medical worth $170K as of Q1 2026.
  • Avanos Medical was a new Odyssean LLC position in Q1 2026.
  • Avanos Medical made up 0.06% of Odyssean LLC's portfolio in Q1 2026, its #385 holding.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Odyssean LLC's 13F filing for Q1 2026, filed 15 May 2026.